Older peoples' views on cardiovascular disease medication: a qualitative study.

Katharine Ann Wallis Denise A TaylorElizabeth F FanueliPadmapriya SaravanakumarSusan Wells

Published in: Family practice (2022)

Findings raise questions about older people's agency in decision-making regarding CVD medication. CVD risk management guidelines for older people could include strategies to support effective communication of the potential benefits and harms of CVD medication in older people, balancing life expectancy, and the expected duration of therapy.

Keyphrases

cardiovascular disease
decision making
adverse drug
healthcare
type diabetes
physical activity
emergency department
middle aged
metabolic syndrome
mesenchymal stem cells
bone marrow
coronary artery disease
drug induced